Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 338-343

  Carlberg, Carsten ^a   Dunlop, Thomas W ^a   Saramäki, Anna ^a   Sinkkonen, Lasse ^a   Matilainen, Merja ^a   Väisänen, Sami ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chromatin; Gene regulation; Nuclear receptor; Response element; Vitamin D; Vitamin D receptor

Indexed keywords

CYCLIN C; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BINDING SITE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; EXON; GENETIC SCREENING; HUMAN; INTRON; NONHUMAN; PROMOTER REGION; RECEPTOR BINDING; REPORTER GENE;

ANIMALS; BINDING SITES; CHROMATIN; COMPUTATIONAL BIOLOGY; HUMANS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 33947166832     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.044     Document Type: Article

References (60)

1. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 (2001) 1866-1870
2. Maglich J.M., Sluder A., Guan X., Shi Y., McKee D.D., Carrick K., Kamdar K., Willson T.M., and Moore J.T. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2 (2001) RESEARCH0029
3. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., and Moras D. Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 5 (2000) 173-179
4. Moras D., and Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10 (1998) 384-391
5. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
6. 3. Crit. Rev. Eukaryot. Gene Expr. 8 (1998) 19-42
7. 3 receptors. Cell 65 (1991) 1255-1266
8. 3. Interplay with retinoid and thyroid hormone signalling. Eur. J. Biochem. 231 (1995) 517-527
9. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
10. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., and Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 361 (1993) 657-660
11. Quack M., and Carlberg C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J. Mol. Biol. 296 (2000) 743-756
12. 3R receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370 (1994) 382-386
13. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol. 15 (1995) 1154-1161
14. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
15. Johnson C.A., O'Neill L.P., Mitchell A., and Turner B.M. Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome. Nucleic Acids Res. 26 (1998) 994-1001
16. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
17. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 (2001) 1269-1304
18. Burke L.J., and Baniahmad A. Co-repressors 2000. FASEB J. 14 (2000) 1876-1888
19. 3 receptor-corepressor partnership. FASEB J. 14 (2000) 1455-1463
20. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66 (2004) 315-360
21. Leo C., and Chen J.D. The SRC family of nuclear receptor coactivators. Gene 245 (2000) 1-11
22. Castillo A.I., Jimenez-Lara A.M., Tolon R.M., and Aranda A. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol. Endocrinol. 13 (1999) 1141-1154
23. 3 receptor in a ligand-dependent manner and enhances transactivation in a cell-free system. Genes Dev. 12 (1998) 1787-1800
24. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Näär A.M., Erdjument-Bromage H., Tempst P., and Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398 (1999) 824-828
25. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6 (2005) 542-554
26. Acevedo M.L., and Kraus W.L. Transcriptional activation by nuclear receptors. Essays Biochem. 40 (2004) 73-88
27. 3 receptor signalling in prostate cancer cells. Oncogene 23 (2004) 6712-6725
28. Burns J.L., Jackson D.A., and Hassan A.B. A view through the clouds of imprinting. FASEB J. 15 (2001) 1694-1703
29. 3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell. Biol. 23 (2003) 3339-3351
30. Mader S., Leroy P., Chen J.-Y., and Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements. J. Biol. Chem. 268 (1993) 591-600
31. Schräder M., Müller K.M., Becker-André M., and Carlberg C. Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors. J. Mol. Endocrinol. 12 (1994) 327-339
32. Schräder M., Müller K.M., and Carlberg C. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J. Biol. Chem. 269 (1994) 5501-5504
33. Schräder M., Becker-Andre M., and Carlberg C. Thyroid hormone receptor functions as monomeric ligand-induced transcription factor on octameric half-sites. Consequences also for dimerization. J. Biol. Chem. 269 (1994) 6444-6449
34. Quack M., Frank C., and Carlberg C. Differential nuclear receptor signalling from DR4-type response elements. J. Cell. Biochem. 86 (2002) 601-612
35. Frank C., Makkonen H., Dunlop T.W., Matilainen M., Väisänen S., and Carlberg C. Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. J. Mol. Biol. 346 (2005) 505-519
36. The ENCODE (ENCyclopedia Of DNA Elements) Project, Science 306 (2004) 636-640.
37. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., and Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31 (2003) 374-378
38. Sutton A.L., and MacDonald P.N. Vitamin D: more than a "bone-a-fide" hormone. Mol. Endocrinol. 17 (2003) 777-791
39. 3 and its analogs on growth control and tumorigenesis. Front. Biosci. 6 (2001) D820-D848
40. Jiang H., Lin J., Su Z.-z., Collart F.R., Huberman E., and Fisher P.B. Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9 (1994) 3397-3406
41. Rickert P., Seghezzi W., Shanahan F., Cho H., and Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12 (1996) 2631-2640
42. Bourbon H.M., Aguilera A., Ansari A.Z., Asturias F.J., Berk A.J., Bjorklund S., Blackwell T.K., Borggrefe T., Carey M., Carlson M., Conaway J.W., Conaway R.C., Emmons S.W., Fondell J.D., Freedman L.P., Fukasawa T., Gustafsson C.M., Han M., He X., Herman P.K., Hinnebusch A.G., Holmberg S., Holstege F.C., Jaehning J.A., Kim Y.J., Kuras L., Leutz A., Lis J.T., Meisterernest M., Naar A.M., Nasmyth K., Parvin J.D., Ptashne M., Reinberg D., Ronne H., Sadowski I., Sakurai H., Sipiczki M., Sternberg P.W., Stillman D.J., Strich R., Struhl K., Svejstrup J.Q., Tuck S., Winston F., Roeder R.G., and Kornberg R.D. A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol. Cell 14 (2004) 553-557
43. Li H., Lahti J.M., Valentine M., Saito M., Reed S.I., Look A.T., and Kidd V.J. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics 32 (1996) 253-259
44. 3. J. Mol. Biol. 350 (2005) 65-77
45. Swami S., Raghavachari N., Muller U.R., Bao Y.P., and Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat. 80 (2003) 49-62
46. 3 in human colon cancer cells. Cancer Res. 63 (2003) 7799-7806
47. 3-responsive regions in its promoter. Nucleic Acids Res. 33 (2005) 2440-2451
48. 3 receptor. Nucleic Acids Res. 34 (2006) 543-554
49. 3. Nucleic Acids Res. 33 (2005) 5521-5532
50. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., and Kellis M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
51. Ogata K., Sato K., and Tahirov T.H. Eukaryotic transcriptional regulatory complexes: cooperativity from near and afar. Curr. Opin. Struct. Biol. 13 (2003) 40-48
52. Wang Q., Carroll J.S., and Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19 (2005) 631-642
53. 3 and its nuclear receptor. J. Mol. Biol. 349 (2005) 248-260
54. Trump D.L., Hershberger P.A., Bernardi R.J., Ahmed S., Muindi J., Fakih M., Yu W.D., and Johnson C.S. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 519-526
55. Evans S.R., Nolla J., Hanfelt J., Shabahang M., Nauta R.J., and Shchepotin I.B. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin. Cancer Res. 4 (1998) 1591-1595
56. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., Gray J.W., and Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25 (2000) 144-146
57. Ingles S.A., Coetzee G.A., Ross R.K., Henderson B.E., Kolonel L.N., Crocitto L., Wang W., and Haile R.W. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res. 58 (1998) 1620-1623
58. Hanchette C.L., and Schwartz G.G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70 (1992) 2861-2869
59. Reed K.R., Sansom O.J., Hayes A.J., Gescher A.J., Winton D.J., Peters J.M., and Clarke A.R. PPARδ status and Apc-mediated tumourigenesis in the mouse intestine. Oncogene 23 (2004) 8992-8996
60. Müller M., and Kersten S. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4 (2003) 315-322